SCHEMBL691870

SCHEMBL691870

Cc1cc(C)c(C(=O)P(=O)(CCCN)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 3/20 0.37
GABBR1 Q9UBS5 3/20 0.37
TSHR P16473 2/20 0.37
CYP1A2 P05177 1/20 0.37
THPO P40225 1/20 0.37
LMNA P02545 4/20 0.37
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BLM P54132 2/20 0.36
CYP3A4 P08684 1/20 0.35
NFKB1 P19838 1/20 0.35
PMP22 Q01453 1/20 0.35
GABRR1 P24046 1/20 0.34
TAS1R3 Q7RTX0 3/20 0.34
TAS1R1 Q7RTX1 3/20 0.34
TAS1R2 Q8TE23 3/20 0.34
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12956433 0.90 LMNA (0.39) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL1035616 0.90 KMT2A (0.40) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL5160037 0.88 KMT2A (0.39) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL2497195 0.85 HPGD (0.41) TSHRLMNAMEN1HPGDKMT2A
SCHEMBL691974 0.83 KMT2A (0.36) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL1034491 0.83 KMT2A (0.36) TSHRLMNAMEN1HPGDKMT2A
SCHEMBL2064034 0.83 ITGB1 (0.41) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL6470163 0.82 LPAR3 (0.40) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL6467886 0.82 LPAR3 (0.40) LMNAMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL6469685 0.82 LPAR3 (0.40) LMNAMEN1HPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US claimed
EP-2451847-B1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES IGM GROUP B V (NL) 2021-11-24 EP disclosed
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-10023675-B2 Polymer nanoparticles ETH ZUERICH (CH) 2018-07-17 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-20160024241-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2016-01-28 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
US-9181358-B2 Polymer nanoparticles ETH ZUERICH (CH) 2015-11-10 US disclosed
EP-2421903-B1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2014-11-19 EP disclosed
US-8883872-B2 Polymer-bound bisacylphosphine oxides BASF SE (DE) 2014-11-11 US disclosed
US-20120142805-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2012-06-07 US disclosed
EP-2451847-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2012-05-16 EP disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
US-20120115963-A1 POLYMER NANOPARTICLES ETH ZUERICH (CH) 2012-05-10 US disclosed
EP-2421903-A1 POLYMER NANOPARTICLES ETH Zurich (CH) 2012-02-29 EP disclosed
WO-2011003772-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2011-01-13 WO disclosed
WO-2010121387-A1 POLYMER NANOPARTICLES ETH Zürich (CH) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024241-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 GABBR2 4315/4885GABBR1 4579/4885TSHR 4311/4885
US-10023675-B2 Polymer nanoparticles POLQ, POLN, POLA1 GABBR2 4315/4885GABBR1 4579/4885TSHR 4311/4885
US-20120115963-A1 POLYMER NANOPARTICLES POLQ, POLN, POLA1 GABBR2 4315/4885GABBR1 4579/4885TSHR 4311/4885
US-20120142805-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES PHOSPHO1, PARG, PEBP1 GABBR2 4372/4885GABBR1 4497/4885TSHR 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.